arrow
W

Wataru Shimizu

national cerebral and cardiovascular center
H指数:107
被引数:4.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease

室性传导是SCN5A-E1784K重叠钠通道疾病中心律失常风险的标志物

2026-05-110
OA
Catheter Ablation Outcomes and Life Expectancy in Very Elderly Atrial Fibrillation Patients

导管消融术结果与极高龄心房颤动患者预期寿命

2025-11-240
PRE
Efficacy and Safety of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Comparison of First-line vs. Second-line Therapy

导管消融治疗阵发性心房颤动的有效性和安全性:一线治疗与二线治疗的比较

2025-07-240
PRE
Adherence to the ABC (atrial fibrillation better care) pathway and risk of adverse outcomes in patients with chronic kidney disease: a report from the prospective APHRS-AF registry

慢性肾脏病患者对ABC(心房颤动更好护理)路径的依从性与不良结局风险:来自前瞻性APHRS-AF登记研究的报告

2025-05-010
OA
International Multicenter Cohort Study on Beta-Blocker-Free Treatment Strategies for Catecholaminergic Polymorphic Ventricular Tachycardia Patients
2025-02-010
PRE
Impact of Catheter Ablation for Atrial Fibrillation on Clinical Outcomes in Hypertrophic Cardiomyopathy: Findings from the REVEAL-HCM Study

心房颤动导管消融对肥厚型心肌病临床结局的影响:REVEAL-HCM研究的结果

2024-11-120
PRE
Impact of Being Underweight on the Safety and Efficacy of Atrial Fibrillation Ablation: An Analysis From the Japanese Catheter Ablation Registry
2024-11-010
PRE
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
2024-11-015
OAAI